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ABSTRACT
Cellular adaptation to microbial stresses has been demonstrated in several cell types.
Macrophages (MФ) are sentinel immune cells fending off invading microbes. Anthrax
lethal toxin (LeTx) is a key virulence factor released by Bacillus anthracis that causes
rapid cell death, pyroptosis. A small number of RAW246.7 macrophages (~4%) exposed
to a non-lethal dose of LeTx become resistant to LeTx-induced pyroptosis for ~ 4 weeks,
termed “toxin-induced resistance (TIR)”. Here, I showed that high levels of DNA methyl
transferase1 (DNMT1) expression were maintained although global genomic methylation
levels were not high in TIR. TIR cells treated with the DNMT inhibitor 5-azacitidine or
(si)RNA targeting DNMT1 became susceptible to LeTx-induced pyroptosis. Knocking
down DNMT1 also increased expression of the mitochondrial cell death proteins Bnip3
and Bnip3L involved in pyroptosis. However, DNA methylation of CpG islands in Bnip3
and Bnip3L were not different between wild type and TIR cells. Among histone
modification genes examined, histone deacetylase (HDAC) 8 was up-regulated in TIR
cells. The HDAC inhibitor panobinostat or siRNAs against HDAC8 rendered TIR cells
sensitive to LeTx-induced pyroptosis and induced Bnip3 and Bnip3L expression.
Acetylation of histone H3 lysine 27 (H3K27Ac) leads to binding of BNIP3 to H3, but this
association was decreased in TIR cells. Also treatments of panobinostat or 5-azacitidine
enhanced the levels of H3K27Ac in TIR cells. Collectively, these results suggest that TIR
was maintained by multiple epigenetic mechanisms through up-regulating expression of
DNMT1 and HDAC8. This resulted in decrease of H3K27Ac and subsequently
suppressed the expression of BNIP3.

Keywords
Bacillus anthracis, anthrax, lethal toxin, toxin induced resistance, epigenetics, DNA
methylation, histone deacetylation, DNA methyl transferase1, Histone deacetlyase 8
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ABBREVIATIONS

Akt

Protein Kinase B

ASC

Apoptosis-Associated Speck-like protein containing a CARD

Bacillus anthracis

B. anthracis

BAH

Two Bromo-Adjacent Homology

BMDM

Bone Marrow Derived Macrophage

BNIP3

Bcl2 Adenovirus E1B-Interacting protein 3

BNIP3L

BNIP3-Like

cAMP

Cyclic Adenosine Monophosphate

CARD

Caspase Activation and Recruitment Domain

CMG2

Cellular Receptor Capillary Morphogenesis gene 2

ChIP

Chromatin Immunoprecipitation

DMAP1

DNA Methyltransferase Associated protein 1

DNMT

DNA Methylatransferase

E.coli

Escherichia coli

EDTA

Ethylenediaminetetraacetic Acid

EdTx

Edema toxins

EF

Edema factor

ERK

Extracellular signal-Regulated Kinases

FBS

Fetal Bovine Serum

GI

Gastrointestinal
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Acetylation of Histone H3 Lysine 27

HATs

Histone Acetyl Transferases

HDACs

Histone Deacetylases

HIF-1

Hypoxia-Inducible Factor 1

IL

Interleukin

IL-18

Interleukin 18

IL-1

Interleukin-1 beta

IPTG

Isopropyl--D-1 thiogalactopyranoside
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JNKs

c-Jun Amino Terminal Kinases

LeTx

Lethal Toxin

LF

Lethal Factor

MAPK

Mitogen Activated Protein Kinases

MBD

Methylation CpG binding domain

MECP2

Methyl CpG binding protein 2

MEK

Mitogen Activated Protein Kinase Kinases

MEKK

MEK kinases

MLN64

Metastatic Lymph Node 64 Protein

MPTP

Mitochondrial Permeability Transition Pore

NLR

NOD-like receptor

NLRP1b (NALP1b)

NOD-like Receptor & Pyrin domain –containing protein

NOD

Nucleotide Oligomerization Domain

NT

Amino-Terminus (N-terminus)

PA

Protective Antigen

PBS

Phosphate Buffered Saline

PI3K

Phosphatidylinositol 3-Kinase (PI3K)

PMSF

Phenyl Methane Sulfonyl Fluoride

qPCR

Quantitative Real Time Polymerase Chain Reaction

RFTS

Replication Foci Targeting Sequence

ROS

Reactive Oxygen Species

RTKs

Transmembrane Receptor Tyrosine Kinases

RT-PCR

Real time Polymerase Chain Reaction

SOS

Son of Sevenless

TEM8

Tumor Endothelial Marker

TIR

Toxin Induced Resistance

TNF-

Tumor Necrosis Factor-Alpha
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CHAPTER 1 - INTRODUCTION
1.1

Anthrax

Anthrax is an acute disease caused by the Gram positive bacterium Bacillus anthracis (B.
anthracis). B. anthracis forms a dormant endospore (referred to as spore) in harsh
conditions and can be revived after decades or even centuries after forming spores1, 2. The
spores germinate after being phagocytosed by macrophages, and toxins expressed after
germination lead to a systematic immune paralysis, shock, and death3. Due to their
stability and obnoxious nature to humans, anthrax spores have been used as a biological
weapon. A recent example is the incident that occurred in the United States in 2001.
Anthrax spores packaged in postal letters were sent to several news media offices and
two democratic senators, resulting in 22 infections and 5 deaths4. In Canada, anthrax
outbreaks have been reported mainly in the southern portions of Ontario and Quebec
during the early 1950’s. These regions were often associated with pastures contaminated
by effluent from textile industries dealing with imported animal materials5. In 1952,
introduction of federal regulations requiring disinfection of these materials greatly
reduced the incidence of anthrax6. In 2006, there was a major outbreak in Saskatchewan7
where dozens of farms were under quarantine and over 200 animals were affected by the
disease. Anthrax can be acquired by any of three known routes: cutaneous (most frequent
and less dangerous), gastrointestinal (rare) and inhalational (rare and extremely
dangerous).8
1.1.1

Cutaneous and gastrointestinal routes

Cutaneous anthrax is caused when the spores enter through cuts on the skin, often after
handling infected animal products. After deposition of spores through abrasion on the
skin, spores geminate in skin tissues and local edema causes the formation of a papule
that resembles a pimple9. Within a few days, the papules develop into fluid filled vesicles
and form a painless necrotic ulcer with a black center, termed eschar. The eschar dries
overtime and finally falls off, leaving a scar. Cutaneous anthrax is rarely fatal, if treated,
because the infection is limited to the skin10. However, without treatments, about 20% of
cutaneous skin infection can progress to toxemia and death.
1

Gastrointestinal anthrax develops a few days after ingesting spore-contaminated meat
from infected animals11. It is generally a result of pre-existing lesions in the upper or
lower gastrointestinal tract, where entry of spores and vegetation of bacteria are possible.
Symptoms of an upper gastrointestinal infection can include oral or esophageal ulceration
leading to the development of regional lymphadenopathy, edema, and sepsis12, 13.
Gastrointestinal infections can be treated but usually result in fatality rates of 25~ 60%,
depending upon the time of initial treatments with antibiotics.
1.1.2

Inhalation route

Inhalation of anthrax spores is considered to be extremely dangerous with a 92%
mortality rate without treatments, but this can be decreased to 45% after rapid treatment
with antibotics14. Inhaled spores are phagocytosed by alveolar macrophages or
pulmonary dendritic cells, and carried to the mediastinal lymph node via the lymphatic
system2, 14. Spores can remain dormant up to 60 days before germinating and, once
germinated, first phase clinical symptoms including malaises, mild fever, and a mild
cough are manifested. In the second phase, bacteria frequently overcomes the lymph node
filter, and enter the lymphatic and blood circulation, rapidly causing massive bacteremia
and toxemia15. This stage is accompanied by major symptoms including fever, enlarged
lymph nodes, pulmonary edema with acute dyspnea (labored respiration), and cyanosis
(bluish discoloration of the skin caused by poor blood oxygenation). The time course of
this second phase is rapid enough such that antibiotics are no longer effective and death
caused by shock is followed. It is believed that the shock is mainly caused by secreted
toxins from live bacteria15, 16.
1.1.3

Treatments & prevention

Early commencement of treatment is essential for anthrax infections because it increases
chances for survival. Similar to other bacterial infections, treatments of anthrax include
large doses of intravenous and oral antibiotics including fluoroquinolones, doxycycline,
erythromycin, vancomycin, and penicillin. There have been many attempts to develop
new drugs against anthrax since existing drugs are not effective enough if treatment is
delayed. In May 2009, Human Genome Sciences submitted an application for its new
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biologic drug, raxibacumab (brand name ABthrax) indicated for emergency treatment of
inhaled anthrax17. It is a monoclonal antibody that neutralizes anthrax toxins that can
cause massive and irreversible tissue injury and death. On Dec 2012, the US Food and
Drug Administration (FDA) approved raxibacumab injection to treat inhalation anthrax17.

1.2.

B. anthracis toxins

B. anthracis produces two anthrax toxins, edema toxin (EdTx) and lethal toxin (LeTx),
derived from the combination of three different factors: protective antigen (PA; 83 kDa),
edema factor (EF; 89 kDa) and lethal factor (LF; 90 kDa) 18. It has been reported that
LeTx and EdTx are required for survival of spore and responsible for eventual death of
infected hosts3. PA functions as a molecular transporter, facilitating the entry of LF and
EF into cells through endocytosis. Assembly of toxin complexes begins after PA binds to
cellular receptors and is cleaved into two fragments by furin-like proteases19. To date,
two host receptors, the tumor endothelial marker (TEM8) and the cellular receptor
capillary morphogenesis gene 2 (CMG2), have been identified to bind PA20, 21. The
current model of toxin entry indicates that full length PA (83 kDa) binds to TEM8 or
GCM2 and is cleaved by furin-like protease at the plasma membrane, leaving cleaved
large form of PA (PA63; 63 kDa) attached to the receptors. Dissociation of the cleaved 20
kDa fragment allows PA63 to form a spontaneous heptameric homo-oligomer that binds to
EF or LF. PA63-EF or –LF complexes induce a lipid raft-mediated clarthrin-dependent
endocytosis21. Once the endosomes are acidified, the complex undergoes conformational
changes, resulting in the insertion of a flexible loop of each PA molecule into the lipid
bilayer and the translocation of EF and LF into the cytosol22. There are two virulence
factors which confer pathogenicity of B. anthracis: a poly D-glutamic acid capsule and
anthrax exotoxins23. These factors are encoded by two different plasmids (pXO1 &
pXO2)19, 23. The poly-D glutamic acid capsule encoded in pXO2 whereas LeTx and EdTx
are encoded by pXO1.
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1.2.1.

EdTx

EF is a Ca2+-calmodulin-dependent adenylate cyclase that causes a prolonged increase of
cytosolic cyclic adenosine monophosphate (cAMP)24. This is a representative example
showing how bacteria can successfully evolve to disrupt a wide array of physiological
processes. EF plays a crucial role in survival of anthrax bacteria in macrophages and
modulation of the cytokine secreted by human monocytes. EF also collaborates with LF
and PA to cause toxemia in the host, leading to death3. Recent studies showed that EdTx
alone can cause widespread tissue damage, multi-organ failure and even death in
BALB/cJ mice24.
1.2.2.

LeTx

LF is a zinc-dependent metalloprotease that cleaves the N-terminal end of mitogen
activated protein kinase kinases (MEK)1 to 7, except MEK5, resulting in the inactivation
of these kinases8. LF is composed of an N-terminal PA binding domain, a central
substrate binding domain and a C-terminal catalytic domain. LeTx targets MEKs and
cleaves several N-terminal acid residues of MEKs, and therefore MEKs cannot escape LF
recognition through mutation without severe consequences in terms of cell physiology25.
LeTx is the major contributor of anthrax progress in infected animals: LeTx alone can
provoke various symptoms manifested in actual infections; the chemical LF inhibitors
protect animal from anthrax26.

1.3.

MAPK Signaling pathway

The MAPK cascade is initiated by phosphorylations of MAPKs by the dual specific
kinase MEKs. MEKs are phosphorylated and activated by MEK kinases (MEKK, e.g.
Raf) that attracted to the plasma membrane by interacting with Ras superfamily
GTPases27. MAPK signaling pathways process extracellular signals, such as
environmental stresses and various cytokines, and promote various cellular functions
including gene transcription. In mammals, five distinct groups of MAPKs were
characterized; among them, the extracellular signal-regulated kinases (ERKs) 1 and 2,
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p38 MAPKs (p38s) and c-Jun amino terminal kinases (JNKs) have been the most
extensively studied28.
1.3.1.

ERK 1 &2

ERK 1 (p44) and ERK 2 (p42) play crucial roles in regulating cell proliferation, cell
differentiation and cell survival. Activation of ERK is typically mediated through the
transmembrane receptor tyrosine kinases (RTKs) that are activated by various cytokines
and growth factors, called mitogens. Mitogens stimulate autophosphorylation of RTKs
and lead to the recruitment of the guanine nucleotide exchange factor SOS (Son of
sevenless). SOS promotes conversion of GDP-bound inactive to GTP-bound active RAS
(GTP-Ras)27. GTP-Ras then interacts with the downstream serine/threonine kinase Raf
(MEKK). Activated Raf phosphorylates and activates MEK1 & 2 to promote the
activation of ERK1 & 227.
1.3.2.

p38

p38 is involved in various macrophage and neutrophil functions, including respiratory
burst activity, chemotaxis, granular exocytosis, adherence and apoptosis, and mediates Tcell differentiation and apoptosis by regulating gamma interferon production29. Four
isoforms of p38 MAPK have been identified and δ), and p38 and p38 are
ubiquitously expressed. MEK4 represents a site of integration for the p38 and JNK
pathways. While MEK6 activates all p38 isoforms, MEK3 is somewhat selective for
p38 and p38 isoforms30. The specificity in p38 activation is initiated by the formation
of functional complexes between MEK3/6 and different p38 isoforms, and the selective
recognition of the activation loop of p38 isoforms by MEK3/6. Activation of p38 results
from the MEK3/6-catalyzed phosphorylation of a conserved Thr-Gly-Tyr (TGY) motif in
p38 activation loop29.
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1.4. LeTx and pyroptosis
1.4.1. LeTx and NOD-like receptors
LeTx causes rapid cell death of macrophages from certain strains of in-bred mice.
Macrophages derived from mice including 129s/j, C3H/Hej and BALB/c undergo rapid
cell death within 5 hours of LeTx exposure; whereas, macrophages derived from DBA/2,
AKR, and C57BL/6 mice undergo slow apoptotic cell death, likely due to inactivation of
MEKs31, 32. Genetic studies on these mice identified the nucleotide oligomerization
domain (NOD)-like receptor & pyrin domain –containing protein (NLRP1b, Gene ID:
637517, also known as NALP1b) responsible for the rapid cell death33. NLRP1b is a
member of the NOD-like receptor (NLR) family and is highly polymorphic. To date, five
polymorphic NLRP1b alleles have been described in mice33. It was shown that only
macrophages harboring a LeTx-sensitive allele undergo rapid cell death by LeTx.
NLRs are a family of intracellular pattern recognition receptors that recognize various
microbial components and endogenous danger associated molecular patterns34. Upon
activation, all NLRs known to date form heterogeneous multimeric oligomers, termed
inflammasomes, that are composed of NLRs, pro-caspase-1 and ASC (apoptosisassociated speck-like). The multi-protein platforms facilitate auto-cleavage of procaspase-1 into highly active caspase-1. Caspase-1 then cleaves the proinflammatory
cytokines, pro-interleukin (IL)-1 and -IL-18 into biologically active IL-1 and IL-18,
respectively, and induces rapid cell death termed “pyroptosis”35. Inflammasomes play a
role for immune cells in discriminating non-virulent and virulent pathogens35; in
response to bacterial virulence factors including type III and IV secretion systems (T3SS
and T4SS), inflammasome, NLRC4 (also known as IPAF) is activated through NLR
signaling, leading to activation of caspase-1. NLRs act as an intracellular pattern
recognition sensor for danger signals in the cytoplasm36. Among the 23 members of the
NLR family in human, only several NLRs have been explored for their function and
activators. Besides NLRP1 activated by LeTx, NLRP3 is activated by microbial pore
forming toxins, crystalline uric acid or uric acid crystals, and extracellular ATP. NLR
family CARD domain-containing protein 4 (NLRC4, also known as IPAF) senses the
presence of flagellin and plays important roles in innate immune responses to gram
6

negative bacteria37. Several cellular events were commonly shown to be required for their
activation, including lysosomal membrane disruption, K+ efflux and reactive oxygen
species (ROS) generation38. However, the exact molecular mechanisms of NLR
activation are largely unknown.
1.4.2. LeTx and pyroptosis
The molecular mechanism of NLRP1b activation by LeTx is yet to be defined. Several
recent studies have shown that NLRP1b undergoes auto- and LF-dependent cleavages,
which is required for its activation39, 40. It was speculated that the cleavage allows the
formation of NLRP1b inflammasome through forming a caspase activation and
recruitment domain (CARD) homotypic interaction with procaspase-141. After NLRP1b
activation, caspase-1 plays an integral role in LeTx-induced pyroptosis; however, how
caspase-1 induces pyroptosis is also enigmatic42. Pyroptosis is a caspase-1-dependent
type of cell death triggered by microbial pathogens, including anthrax lethal toxin,
Salmonella spp. Shigella spp, and Listeria spp43, 44 and various danger-associated
molecular patterns. In the process of pyroptosis, DNA damage occurs and its process is
caspase dependent45. Caspase-1 is activated during pyroptosis by a large supramolecular
complex termed the pyroptosome , which is largely composed of dimers of the adaptor
protein ASC (also known as an inflammasome)46. Pyroptosis results in the release of
pathogen associated molecular patterns (PAMPs) and cytokines that activate proinflammatory immune cell mediators47. In the process of pyroptosis, cell lysis occurs
upon the formation of pores in the cell membrane, which disrupts the cellular ionic
gradient, leading to an increase in osmotic pressure followed by cell swelling and
bursting. At the same time, the cytosolic contents release via the channels of the pores48.
Subsequently, caspase-1 cleaves pro-inflammatory cytokines, resulting in activation.
Moreover, DNA cleavage with retained integrity and nuclear condensation has been
associated with the process. Several cellular events are reported to be required for LeTxinduced pyroptosis, including early mitochondrial dysfunction49, 50 , lysosomal
permeablization51, Ca2+influx 52, 53, and generation of reactive oxygen species (ROS) 54.
However, whether these events are required for caspase-1 activation or downstream of
caspase-1 activation is still to be examined. We previously showed that LeTx causes
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distinct characteristics of mitochondrial dysfunction from those by NLRP3, which is
dependent on NLRP1b/caspase-1 and at least in part mediated through the three
mitochondrial cell death genes: Bcl2 adenovirus E1B-interacting protein 3 (BNIP3) and
BNIP3-like (BNIP3L) and metastatic lymph node 64 protein (MLN64)50, 55.
1.4.3. The mitochondrial cell death proteins BNIP3 & BNIP3L
Early mitochondrial dysfunction induced by LeTx in LeTx-susceptible macrophages has
been documented by us50, 55 and others49. LeTx causes a loss of mitochondrial membrane
potential and mitochondrial succinate dehydrogenase activity. Mitochondrial impairment
and pyroptosis by LeTx requires proteasome activities, and the proteasome inhibitor
MG132 prevented the mitochondrial dysfunction49. Our studies have also shown that
LeTx causes mitochondrial dysfunction, manifested by early hyperpolarization, followed
by rapid depolarization, ROS generation and depletion of free glutathione55. In addition,
the mitochondrial cell death proteins BNIP3 and BNIP3L were also involved in the
mitochondrial dysfunction. However, the molecular mechanisms of these proteins in
inducing mitochondrial dysfunction are still unknown.
BNIP3 was first discovered 1994 in a yeast two hybrid screen using a B cell cDNA
library as one of three novel proteins that interact with the adenovirus E1B19K protein56.
BNIP3 predominantly localizes to the mitochondria56, 57, where it is integrated into the
mitochondrial membrane through its transmembrane N-terminal regions56 . Previous
studies suggested that BNIP3 is a weak inducer of cell death that cause loss of
mitochondrial hyperpolarization, opening of the Mitochondrial Permeability Transition
Pore (MPTP), and release of cytochrome c 58. Overexpression of BNIP3 induces loss of
mitochondrial membrane and cell death. However, the exact mechanism of how BNIP3
disrupts mitochondrial function is still elusive. It has been reported that BNIP3
expression is increased under hypoxic conditions and regulated by the transcription factor,
hypoxia-inducible factor 1(HIF-1)59, 60. BNIP3 is a key regulatory gene in hypoxiainduced cell death61, 62. In addition, increased expression of BNIP3 leads to cell death in
cardiac myocytes and other cultured cell lines. BNIP3L is a homolog of BNIP3 (also
called NIX) and localizes to the nuclear envelope, endoplasmic reticulum, and
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mitochondria. BNIP3L activates downstream effectors Bax/Bak through interacting with
anti-apoptotic Bcl-2 and Bcl-XL63.
BNIP3 and BNIP3L are also known to be involved in autophagy. Daido et al. first
described a role for BNIP3 in autophagy in the ceramide-induced autophagic death of
malignant glioma cells64. In these cells, ceramide induced an increase in BNIP3
expression, and BNIP3 causes mitochondrial depolarization and autophagy. In an
ischemia-reperfusion model, BNIP3 induced autophagy, which protected HL-1 myocytes
from cell death65. Similarly, hypoxia-induced BNIP3 increased autophagic death, but
protected Saos2 cells from necrosis-type cell death66. Thus, BNIP3 and BNIP3L exhibit a
dual function; they induce cell death, and they also participate in the induction of
autophagy.
Expression of BNIP3 and BNIP3L was also known to be epigenetically modified in
various colon carcinoma and hematopoietic cell lines. Murai et al. reported that
methylation of the 5’CpG islands of BNIP3 was correlated with silencing of the gene in
colon carcinoma line67. Treatment of BNIP3 with azacitidine restored expression of
BNIP3 mRNA and protein, leading to cell death. In addition, acetylation of histone H3 in
5′ region of the BNIP3, is correlated with gene expression and inversely with DNA
methylation in a hematopoietic cell line68.

1.5. Cellular adaptation of macrophages to LeTx-induced pyroptosis
We and others showed that macrophages pre-exposed to sub-lethal doses of LeTx are
refractory to subsequent high cytolytic doses of LeTx. This phenomenon is termed toxin
induced resistance (TIR)50, 69. Salles et al. showed that macrophages, such as RAW 264.7
and J774A.1 cells, exposed to a low dose of LeTx become resistance to subsequent high
doses of LeTx for 4 days69. We further showed that a small portion of TIR cells (2-4%)
retain TIR characteristics for up to 5 to 6 weeks. These TIR cells show no defect in in
cleaving MEKs in response to LeTx treatments, suggesting that uptake of LeTx into the
cytoplasm is normal 50. For the mechanism of TIR, an adaptive ERK activation by a
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MEK-independent process or a general decrease in proteasome activity was suggested69.
Since ERK has not yet been shown to be protective in pyroptosis, its involvement in TIR
is not clear. Proteasome activity was shown to be required for LeTx-induced caspase-1
activation and pyroptosis49. However, we showed that TIR cells are also normal in
activating NLRP1b and caspase-1 in response to LeTx, suggesting that the decrease of
proteasome activity may be responsible for TIR at most in part.
A genome-wide micro-array study compared mRNAs between wild-type and TIR found
that expression of BNIP3 and BNIP3L were significantly down regulated in TIR cells
(Fig 1.1)50. Furthermore, we have shown that TIR cells are mainly resistant to NLRP1inflammasome-induced mitochondrial dysfunction, including mitochondrial innermembrane hyperpolarization, generation of reactive oxygen species and depletion of the
anti-oxidant glutathione55. However, to date, how BNIP3 and BNIP3L are down
regulated in TIR cells is elusive.
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Fig 1.1. Sequence of cellular events involved in LeTx-induced cell cycle arrest and
pyroptosis.
LF released from endosome causes mitochondrial dysfunction which requires Bnip3 and
Bnip3L, resulting in cell death, known as pyroptosis. LF also cleaves MEKs, resulting in
cell cycle arrest. Arrow () indicates activation.
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1.6. Epigenetics
The term, ‘epigenetics’ (epi, επί in Greek, means over, above or outer), literally implies
‘outside conventional genetics’ and is used to describe stable alteration in gene
expression or cellular phenotype caused by mechanisms other than changes to the DNA
nucleotide sequence70. DNA methylation and histone modifications are two types of
epigenetic mechanisms that regulate gene expression without altering the underlying
DNA sequence. Other epigenetic mechanisms such as ubiquitination, phosphorylation,
and sumoylation have been studied for histone modification. Epigenetic changes may be
sustained through cell divisions for the remaining life of the cell and may also last for
multiple generations of cells71.
1.6.1. DNA methylation and regulation of gene expression
DNA methylation is a mechanism which methylates cytosine residues at specific
positions in the DNA molecule, resulting in repression of gene transcription72, 73. DNA
methylation is involved in key biological processes including differentiation, imprinting,
and X chromosome inactivation70 . Failure to maintain proper DNA methylation results
in developmental disorders as well as cancer74. CpG sites are regions of DNA where
a cytosine nucleotide locates next to a guanine nucleotide in the linear sequence of bases.
These sites are the main locations where most DNA methylation occurs. Methylation of
CpG dinucleotide is catalyzed by DNA methyltransferases (DNMTs), which transfers the
methyl moiety from the methyl donor S-adenosylmethionine to the 5’ position of the
cytosine ring. There are three main DNA methyltransferases (DNMTs; DNMT3a, 3b and
DNMT1). DNMT3a and 3b are required for de novo methylation, whereas DNMT1 is
involved in the maintenance of DNA methylation patterns from parental to progeny
cells75 and has a preference for methylating hemimethylated DNA 72, 76. DNMT1 is a 195
kDa nuclear protein that harbors the DNMT catalytic domain in its C terminus and there
are several regulatory domains in the N terminus, which are the DNA methyltransferase
associated protein 1 (DMAP1)-binding domain, the Replication Foci Targeting Sequence
(RFTS) domain, the CxxC zinc binding domain and two Bromo-Adjacent Homology
(BAH) domains. Thirteen alternating repeats of Gly-Lys residues link the regulatory with
the catalytic domain77. For repression of genes, the most critical signal is initiation of
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repression by DNA itself. Methyl groups bound to the cytosine residues situated 5’ to
guanosines in DNA, so called CpG islands, are directly responsible for the recruitment of
the HDAC complex via proteins such as methylated CpG binding proteins (MeCP2) and
methyl CpG biding domain containing proteins (MBD), or via the enzymes that
methylate the CpG islands, the DNA methyltransferase78, 79.
1.6.2. Histone & Chromatin
In the nucleus, DNA is wrapped around the four core histone proteins H3, H4, H2B, and
H2A to form the nucleosome which is the fundamental repeating unit of chromatin80.
These nucleosomes are condensed into higher order structures which form chromosomes.
This is required for efficient packaging of DNA into the nucleus of the cell. When DNAs
are compacted into the structure, its accessibility becomes greatly limited, and this serves
as a mechanism by which the cell regulates DNA mediated processes such as
transcription, DNA replication, and DNA repair81, 82. Each histone is composed of a
conserved globular histone-fold domain, and extended N and C-terminal tails. The
globular domains of the histone proteins form the nucleosome core, wrapped around by
146 base pair-long DNAs. The extended histone tails protrude beyond the DNA and into
the nucleoplasm. These tails serve as the sites of a variety of post-translational
modifications, such as acetylation, methylation, ubiquitination and phosphorylation81, 83.
The presence or absence of certain post-translational modifications allows localized decondensation or condensation of the chromatin. These localized changes in chromatin
structure can exert positive or negative regulatory effects on DNA-mediated processes
such as gene regulation, DNA repair and DNA replication81, 82
1.6.3. Histone modifications and regulation of gene expression
Histones can undergo multiple post-translational modifications, which mainly occur
along their N-terminal tails82. The histones possess polypeptide amino-terminal tails rich
in positively charged lysine residues that are attracted to the negatively charged DNA.
Neutralization of the positive charges by acetylation promotes gene transcription.
Genome-wide studies showed that various combinations of histone modifications in a
specific genomic region can lead to the activation or repression of gene expression84. For
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example, histone methylation or acetylation can play a key role in the maintenance of
both active and suppressed states of gene expression, depending on the position of
methylation. It was shown that trimethylation of lysines (K) positioned on 4, 36, or 79 on
H3 (H3K4me3 , H3K36me3, and H3K79me3, respectively), monomethylation of H4K20
and H2K5 (H4K20me and H2BK5me) , and acetylation of H3K9 and H3K14 result in
gene activation, whereas di- or trimethylation of H3K9 (H3K9me2 and H3K9me3) and
H3K27 (H3K27me3) lead to gene repression82, 85.
1.6.3.1. Histone acetylation and gene expression regulation
Acetylation neutralizes the positively charged lysine residues of the histone N-termini,
decreasing their affinity for DNA, which cause nucleosome unfolding and increases
access of transcription factor to the promoter86. Histone acetyl transferase (HAT) is an
enzyme that acetylates conserved lysine amino acids or histone proteins by transferring
an acetyl group from acetyl CoA to form ε-N-acetyl (Lysine amino acid of acetyl group).
It neutralizes positively charged lysine residues, leading to reduction of affinity between
histone and negatively charged DNA. Also it can acetylate non histone proteins, such as
transcription factors and nuclear receptors to facilitate gene expression. Increased histone
acetylation by HAT is a key feature of transcriptionally active chromatin and it is also
integral to the histone assembly and cell replication mechanism80. HATs can be largely
categorized into two classes87, 88. Type A HATs are localized in nuclei and most likely
acetylate nuclesomal histones and transcriptional activation. By contrast, type B HATs
can be purified from cytoplasmic fractions, and these activities are responsible for
acetylating newly synthesized histone before chromatin assembly during DNA
replication80, 87. Most HAT associated transcriptional coactivators contain bromodomains.
Bromodomains bind to acetylated lysines with ligand selectivity because of
conformational differences in the loops89. The CBP bromodomain specifically binds
acetylated Lys382 in the COOH terminus of p53, which is responsible for co-activator
recruitment by p53 after DNA damage90. Gene expression is regulated by the balance of
histone acetylation and deacetylation on lysine residues in the N-terminal tails.
Disturbing the balance between HAT and HDAC may disturb gene transcription as well
as DNA replication.
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1.6.3.2. Histone deacetylase (HDAC)
Histone deacetylases (HDACs) are enzymes that can remove acetyl groups from a ε-Nacetyl (Lysine amino acid of acetyl group) on a histone so that histones can wrap DNA
more tightly, leading to chromatin compaction and transcriptional repression91. Histone
deacetlyation is considered to suppress the expression of several genes that regulate cell
growth and differentiation. HDACs are divided into two subfamilies: the Zn2+ dependent
HDAC class (class I, II, and IV) and NAD (Nicotinamide adenine dinucleotide)+
dependent sirtuins (SIRT; class III). Class I HDACs, which show significant homology to
the yeast protein RPD3, include HDAC 1,2,3,8, and 11 that are primarily nuclear and
ubiquitously expressed, whereas class II HDACs include HDAC 4, 5, 6, 7, 9, and 10
which are homologous to yeast HAD-1 like enzymes, and they are primarily localized to
the cytoplasm but are known to shuttle in and out of the nucleus 91. Class I HDACs are
widely expressed and is found in most cell types, whereas class II HDACs appear to have
more restricted distribution and may be involved in cellular differentiation92, 93. It is
clearly known that HDAC enzymes usually operate along with other enzyme to silence
genes. For taking these functions such as co-repression or chromatin remodeling, many
proteins are recruited, result in repressor complex.
1.6.3.3. DNA methylation and histone modification inter-relationship.
Previously, several mechanisms were reported that DNMT1 and HDACs co-operatively
work and induces silencing of genes94, 95. For example, Jones et al. suggested that
methylated DNA and MeCP2 recruit HDACs, leading to gene silence94. Gene silencing
can be caused by both histone deacetylation and methylation (Fig 1.2.), but the action of
methylation is indirect and has no effect upon charge86. It also has been shown that
methylation at a specific lysine residue (K4) in histone 3 is required for targeting histone
tails for continuous acetylation and deacetylation82. Valeria Santini et al. also suggested
that action of methyl binding proteins and histone deacetylases, and the DNA structure
changes to a compact, condensed chromatin configuration, result in permanent inhibition
of messenger RNA and protein production96. Further, hypomethylating agents and
histone deacetylase inhibitors act synergistically to restore functional gene expression.
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Fig 1.2. Silencing gene expression by DNA methylation and Histone deacetylation
DNA methyltransferases incorporate methyl group into cytosine residues of CpG
dinucleotides. Histone deacetylases then bind to the methylated DNA and induce a closed
configuration of chromatin. Transcription factors are dissociated from DNA and gene
transcription is repressed96.
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1.7. Rationale, Hypothesis and Objectives
TIR is a cellular phenomenon maintained throughout multiple cycles of cell division.
Therefore, I hypothesized that TIR is mediated through epigenetic reprogramming. In
order to address the hypothesis, the following objectives were proposed:
1. Examining the effects of various chemical epigenetic inhibitors on TIR
2. Examining whether specific DNA methylation and/or histone acetylation enzymes are
involved in TIR
3. Examining if epigenetic reprogramming regulates expression of BNIP3 and BNIP3L in
TIR cells
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CHAPTER 2 - MATERIALS & METHODS
2.1. Cell culture & reagents
RAW 264.7 murine macrophages were cultured in Dulbecco's modified Eagle's medium
containing 8% heated-inactivated fetal bovine serum (Sigma-Aldrich), 10 mM MEM
non-essential amino acids solution, 100 units/ml penicillin G sodium, 100 μg/ml
streptomycin sulfate, and 1 mM sodium pyruvate. Cells were grown at 37°C in a
humidified atmosphere of 5% CO2.
Bone marrow-derived immortalized macrophages (BMDIM) from C57BL/6J mice were
generated as described previously90, 91. Briefly, bone marrow cells were transfected with
the J2 murine retrovirus, which carries the v-raf and v-myc oncogenes, and cultured for 7
days in macrophage-driving medium containing macrophage colony-stimulating factor91.
Cells were then cultured with normal medium (RPMI 1640 medium containing 10% heatinactivated fetal bovine serum, 10 mM MEM nonessential amino acids solution, 100
U/ml penicillin G sodium, 100 μg/mL streptomycin sulfate, and 1 mM sodium pyruvate).
TIR cells were generated as previously reported45. Briefly, RAW 264.7 macrophages
treated with LeTx (500 ng/ml LF and 1g/ml PA) for 5 hours, and surviving cells were
plated in a fresh cell culture media . Two weeks later surviving clones were individually
picked and plated on a 96-well plate. Each clone was duplicated, and tested for LeTx
sensitivity, and LeTx resistant clones were pooled and propagated.
Epigenetic inhibitors used in this study were as follows. For reagents, various epigenetic
inhibitors, Aza-2-deoxycytidine (Sigma,Canada), Panobinostat (Selleck,Texas),
Tozasertib (LC Lab, Boston), and Anacardic acid (Santa cruz biotech, California) were
obtained from indicated sources. The antibody raised against N-terminus of MEK 1 was
obtained from QED Bioscience Inc. Pan and specific antibodies raised against p38
MAPK, ERK1/2, and MEK1 (COOH terminus of MEK1) were obtained from cell
signaling technologies (Pickering, Ontario, Canada). Antibody raised against H3K27Ac
was purchased from Active Motif, California.
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2.1.1. Epigenetic inhibitor treatment
For treatment of epigenetic inhibitors, stock solutions of Aza-2-deoxycytidine as a DNA
methyl transferase inhibitor (DNMTi), Panobinostat as a Histone deacetylase inhibitor
(HDACi), Tozasertib as a pan aurora protein kinase inhibitor, and Anacardic acid as a
histone acetyl transferase (HAT) inhibitor were dissolved in DMSO. Wild type (RAW
264.7 macrophage cells) and TIR cells were incubated with respective inhibitors at the
indicated concentration and time.

2.2. Preparation of anthrax lethal toxin
Protective antigen (PA) and lethal factor (LF) were purified as previously described49.
Protective Antigen: PA was purified from the E. coli expression strain BL21 (DE3)
bearing the plasmid construct (PET22B-PA). Overnight cultures were added to Luria
broth containing ampicillin (50 g/mL). Cultures were grown with shaking at 37 ºC until
OD 600 of 1.0 was reached. Isopropyl -D-1 thiogalactopyranoside (IPTG) was added to
0.5 mM, and incubated with shaking at 30 ºC for additional 3-4 hours. Cells were
harvested by centrifugation, re-suspended in a hypertonic solution with 30 mM Tris-HCl,
pH 8.0, 20% sucrose, 1mm Ethylenediaminetetraacetic acid (EDTA) and incubated at
room temperature for 10 min. Cells were pelleted again and resuspended in an isotonic
solution with 20 mM of MgSO4 and incubated on ice for 30 min.
Lethal Factor: LF was purified from Bacillus mageterium transformed with LF
expressing plasmid (pWT-1520-LF). Overnight cultures were added to Luria broth
containing tetracycline (10 mg/ml). Cultures were grown with shaking at 37ºC until OD
600 of 0.3 was reached. Expression of LF was induced by adding 0.5% xylose into the
culture and grown for an additional 8 hours. PA containing cell lysate and LF containing
culture media were precipitated with 80% (NH4)2SO4, and the precipitated proteins were
pelleted by centrifugation. The pellets were resuspended in 20 mM Tris-HCl (pH8.6)
with 1 mM phenylmethanesulfonylfluoride (PMSF), and dialyzed using dialysis tubing
30, 000 MWCO (Sigma). Samples were loaded onto a Q-Sepharose anion exchange
column (Amersham) and proteins were isolated with an AKTA FPLC chromatography
system (GE, USA). Active fractions were combined and dialyzed with PBS.
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2.3. Cytotoxicity assay
RAW 264.7 macrophages cells were cultured with or without LeTx in 96-well plates for
5 hours, and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide was then
added at a final concentration of 1 mg/mL. After incubating at 37 °C for additional 2
hours, culture medium was carefully aspirated, and 100 μL of dimethyl sulfoxide was
added to dissolve crystals. Optical densities of the wells were analyzed using micro plate
reader at 570 nm. The ratio of cell survival was estimated based on the optical density of
wells by comparison with non-treated cells as 100% survival.

2.4. Total cell lysate preparation and immunoblot analysis
Total cell lysate extraction and Western blotting analysis was performed as previously
described31. Briefly, cells were lysed in ice-cold cell lysis buffer (20 mM Tris-HCl 2 mM
EGTA, 5 mM EDTA, 1 mM Na3VO4, 40 mM β-glycerophosphate, 30 mM sodium fluoride,
20mM sodium pyrophosphate, pH7.2) containing 1% Triton X-100, and protease
inhibitor mixtures (Roche Applied Science). Cell lysates were incubated on ice for 10
min and then centrifuged at 12,500 rpm for 10 min at 4 ºC. These extracts were
electrophoretically resolved in 10% SDS-PAGE gels, followed by transfer onto
nitrocellulose membranes. Membranes were subsequently blocked at room temperature
for 1 h with 5% (w/v) skim milk, and then incubated overnight at room temperature with
antibodies. After extensive washing with TTBS ( 20 mM Tris pH 7.5, 150 Mm NaCl, and
0.2% Tween 20), the secondary antibody was applied at 1:40, 000 dilution and incubated
for 60 min. Exposure was performed and analyzed by Odyssey fluorescence imaging
system (LI-COR Inc. USA).

2.5. Quantitative Real-time PCR (qPCR)
Expression of mRNAs was quantified on a Rotor-Gene RG3000 quantitative multiplex
PCR instrument (Montreal Biotech) using Express SYBR Green ER qPCR Super Master
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Mix (Invitrogen). Briefly, total cellular RNA was isolated using TRIzol (Invitrogen)
according to the manufacturer's instructions and then 2 g of total RNA was reverse
transcribed using oligo (dT) primers and Moloney murine leukemia virus (M-MuLV)
reverse transcriptase (New England Biotechnology).The amplification mix (20 μL)
contained a cDNA template derived from 1g of total RNA, diluted to an amount of ~100
ng of cDNA, 500 nM of each specific primer set, 10 μL Express SYBR Green ER qPCR
master mix with ROX (Invitrogen), which contains dNTP, SYBR Green, hot-start fast
Taq polymerase and buffer and DNase-free water. The PCR conditions were as follows:
95 °C for 3min to activate hot start Taq polymerase, then 40 cycles of 95 °C for 15 sec,
58 °C for 30 sec,72 °C for 25 sec final incubation at 83°C for 15sec. Fluorescence
detection was performed immediately at the end of each annealing step.

2.6. Small interfering RNA transfection
Small interfering RNA (siRNA) oligonucleotides directed against mouse DNMT1, and
HDAC8 were purchased from Qiagen. Transfection of RAW 264.7 cell with siRNA was
performed with Lipofectamine RNAi Max (Invitrogen) kit according to the
manufacturer’s instruction. Levels of mRNA expression were confirmed by quantitative
real-time PCR. Quantitative real time PCR Primers used for DNMT1, and HDAC8 are
listed in Table 1.1.

2.7. Global DNA methylation analysis
Global DNA methylation was measured using the Methylamp Global DNA methylation
quantification Kit (Epigentek, USA) as per the manufacturers’ instructions. The kit yields
accurately measures the methylcytosine content as a percentage of total cytosine content.
Briefly, 200 ng of genomic DNA was purified for cell samples using DNEasy blood and
tissue kit (Qiagen) and then it was added to the strip well with high affinity to the DNA
and incubated for 2 hours at 37ºC. The methylated fraction of DNA can be recognized by
sequential incubation with 5-methylcytosine antibody for 1 hour at 37ºC, and secondary
antibody for 1 hour at room temperature. A colorimetric reaction allowed to quantify
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DNA methylation; the quantity of methylated DNA is proportional to the optical density.
Optical densities of the wells were analyzed using micro plate reader at 450 nm. A 50%
methylated DNA was used as a positive control and 0% methylated DNA was used as a
negative control.
5-mC % = (Sample OD – ME3 OD) ÷S x 100
(ME4 OD – ME3 OD) x 2* ÷P

2.8. Bisulfite sequencing
2.8.1. Bisulfite genomic DNA sequencing
Bisulfite treatment For bisulfite-PCR, genomic DNA was purified from wild type
(RAW 264.7 macrophage) and TIR cells using DNeasy Blood & Tissue Kit (Qiagen).
Genomic DNA was treated with sodium bisulfite using Epitect bisulfite kit (Qiagen) as
per the manufacturer’s instruction. In brief, 2 g DNA and 140 LEpitect bisulfite
reaction buffers containing sodium bisulfite and protection buffer were mixed and
modified by bisulfite mediated conversion in thermal cycler under the following
condition: 99°C for 5 min, 60°C for 25 min; 99°C for 5 min, 60°C for 85 min; 99°C for 5
min, 60°C for 170 min. Samples were then purified using EpiTect spin column and eluted
with 20 μL Buffer EB.
Bisulfite PCR, Bisulfite treated DNA was amplified using forward and reverse primers
listed in Table 1.1. Bisulfite primer targeting CpG site was designed through Li lab meth
primer site92 (http://itsa. ucsf.edu/~urolab/methprimer). The PCR was performed on a
thermalcycler (Stratagene, La Jolla, CA) containing 200 µM dNTPs, 2 mM MgCl2, 0.3
µM forward and reverse primers and 0.5 units of Taq polymerase (NEB). The PCR
conditions were as follows: 95 °C for 3 min, then 33 cycles of 95 °C for 1 min, 55 °C for
1 min and 72 °C for 1 min. A final incubation at 72 °C for 15 min concluded the PCR.
PCR products were verified by gel electrophoresis and purified using gel purification.
Bisulfite sequencing For bisulfite-sequencing, the PCR products obtained with
Bisulfite-PCR were cloned into PGEM-T easy vector cloning system (Promega) on LB25

Ampicillin plate. After that, 5 clones were selected and the plasmid DNA was then
purified using plasmid purification system (Bioscience Inc). Purified clones are
sequenced using M13 by London Regional Genomic Center (London, Ontario, CA).
2.8.2. Bisulfite pyrosequencing
Bisulfite PCR Bisulfite pyrosequencing was used for quantitative methylation analysis of
the mitochondrial cell death genes, BNIP3 & BNIP3L. For preparation of samples,
genomic DNA from wild type and TIR cells were isolated with DNEasy blood & tissue
kit (Qiagen Cat No 69504.) and then bisulfite conversion of the genomic DNA was
performed with the EpiTect Bisulfite Kit (Qiagen Cat No. 59104). Methylation states of
CpG’s were amplified using 20 ng of bisulfite-converted genomic DNA for two samples
(wild type and TIR) and 0.2 µM of forward and reverse primers, one of which was
biotinylated. PCR reactions were performed using the Pyromark PCR kit (Qiagen)
optimized for bisulfite-treated DNA. PCR amplification of bisulfite-treated DNA was
performed in 25 µL reactions containing 2 μL (1 U) Hot start Taq DNA polymerase
(Qiagen), 2.5 μL 10X PCR buffer, 20 mM MgCl2, 0.5 μl 10 mM dNTP mix, 1.0 μL (10
pmol) of each forward and reverse primers, 18 μL (∼100 ng) bisulfite treated template
DNA and 18 μL PCR-grade water. PCR was carried out with an initial denaturation step
at 95 °C for 5 min, 35 cycles of 95°C for 30 s, primer-specific annealing temperature
(54 °C for BNIP3 & BNIP3L) for 30 s, elongation at 72 °C for 45 s and a final extension
step at 72 °C for 5 min.
Pyrosequencing & analysis Bisulfite pyrosequencing was performed on a PyroMark
Q24 Pyrosequencing System with the PyroMark Gold Q24 Reagents Kit. Pyro Q-CpG
software (Biotage, Uppsala, Sweden) was used for data analysis. To demonstrate if
amplification was sufficient, samples were run on QIAXcel capillary electrophoresis

2.9. Chromatin immunoprecipitation (ChIP) analysis
30 million RAW 264.7 cells were cross-linked with 1% formaldehyde and lysed in Lysis
buffer [50 mM Tris at pH 8.0, 5 mM EDTA, and 1% sodium dodecyl sulfate (SDS)]
supplemented with protease inhibitors (Thermo Scientific). Chromatin was sheared by
sonication (Bioruptor UCD-200 ultrasound sonicator from Diagenode) for 20 mins
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resulting in DNA fragments between 150 and 200 bp in size. After centrifugation to
remove cell debris at 12,500 rpm for 10 mins, 5% of the sample was kept as INPUT and
then diluted 10 times in dilution buffer [50 mM Tris at pH 8.0, 0.5% Triton X-100, 0.1 M
NaCl, and 2 mM EDTA] supplemented with protease inhibitors. The rest of the soluble
chromatin fraction was recovered and precleared for 1 hour at 4ºC with a mixture of
Protein A and G-conjugated Dynabeads (Invitrogen). Before immunoprecipitation, 50 L
of Dynabeads protein G was incubated with 6 g of anti-H3K27Ac antibody (Active
motif, California) or -IgG rabbit antibody (Sigma) for 2 hours at 4ºC to evaluate the
presence of nonspecific interaction. Chromatin was immnoprecipitated overnight at 4ºC
with antibody-conjugated Dynabeads. The immunoprecipitates were extensively washed
with the following combination of wash buffers (Each wash step was performed for 10
mins); high salt RIPA buffer [10 mM Tris (pH 8.0), 500 mM NaCl, 1 mM EDTA, 1%
TritonX-100, 0.1% SDS, 0.1% DOC, and protease inhibitor cocktail], LiCl wash buffer
[10 mM Tris-HCl (pH 8.0), 250 mM LiCl, 1 mM EDTA, 0.5% NP40, and 0.5% DOC],
and TE buffer [10 mM Tris-HCl (pH 8.0) and 1 mM EDTA]. Bound chromatin and input
DNA were placed in elution buffer [10 mM Tris (pH 8.0), 5 mM EDTA, 300mM NaCl,
and 0.5% SDS] and, heated overnight at 65ºC to reverse the cross-linking. After
proteinase K digestion (100 μg, 1 hour at 50°C), DNA fragments were purified on
QIAquick Spin columns (Qiagen) in 50 μL of EB (elution buffer) and then 1 μL of that
was used in each quantitative real-time PCR analysis. Sequences of promoter-specific
primers are available in listed table 1.1. Sequences of primers were designed to
specifically amplify proximal promoter regions from the genes BNIP3 and BNIP3L. Data
are presented as enrichment of the precipitated target sequence as compared to input
DNA.

2.10. Statistical analysis
Data are presented as Mean ± SE. Statistically significant differences were determined
by unpaired student t-test using GraphPad software.
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Table 1.1. List of primer sequences
Gene

Gene

Primer sequence (5’→ 3’)

Bisulfitesequencing

BNIP3

F:5’-TGAAGTTAGGTTGGAGGTGGGTAGA-3’
R:5’-AACAAAAAAAACAAACTCAACACCCAAAAC-3’

BNIP3

F:5′-GCTCCCAGACACCACAAGAT-3′
R:5′-TGAGAGTAGCTGTGCGCTTC-3′

BNIP3L

F:5′-CCTCGTCTTCCATCCACAAT-3′
R:5′-GTCCCTGCTGGTATGCATCT-3′

DNMT1

F:5’-AAGAATGGTGTTGTCTACCGAC-3’
R:5’-CATCCAGGTTGCTCCCCTTG-3’

DNMT3a

F:5’-ATGTGGTTCGGAGATGGCAAG-3’
R: 5’ AGATGGCTTTGCGGTACATGG-3’

DNMT3b

F: 5’-CCTGTGGAGTTTCCGGCTAC-3’
R: 5’- GACGCTCTTAGGTGTCACTTC-3’

HDAC1

F: 5’-TGAAGCCTCACCGAATCCG -3’
R: 5’-GGGCGAATAGAACGCAGGA-3’

HDAC2

F: 5’-GGAGGAGGCTACACAATCCG-3’
R: 5’-TCTGGAGTGTTCTGGTTTGTCA-3’

HDAC5

F: 5’-AGCACCGAGGTAAAGCTGAG-3’
R: 5’-GAACTCTGGTCCAAAGAAGCG-3’

HDAC8

F: 5’-ACGGGAAGTGTAAAGTAGCCA-3’
R: 5’-TCCACGTAGAGAATACGGTCAAA-3’

HDAC9

F: 5’-GAGAGGCATCGCAGAGAGC-3’
R: 5’-CCCACGGAATGATTCTTTCCA-3’

GAPDH

F: 5′-GCATTGTGGAAGGGCTCATG-3′
R: 5′-TTGCTGTTGAAGTCGCAGGAG-3

BNIP3

F: 5’-AATCTGTCCCTCAACGGCTG-3’
R: 5’-GTTGGTAGATGCACCAGGCT-3’

BNIP3L

F: 5’-TCTTCCTCCAGTCCTACCCA-3’
R: 5’-CCTGGGACAGTGTTAGCCTC-3’

GAPDH

F:5′-GCTGACATCAACTCCCAGGT-3′
R:5′-TTCCGTTCTCAGCCTTGACT-3′

Real time
PCR

ChIP
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CHAPTER 3 - RESULTS
3.1 Obtaining and characterizing TIR macrophages.
3.1.1. Obtaining TIR macrophages.
Although RAW 264.7 macrophages underwent cell death (~98%) by LeTx (500 ng/ml
LF and 1g/ml PA for 24 h), a small population of the surviving macrophages (~4%)
remained resistant even after 6 weeks of the initial LeTx treatment. Based on MTT assays,
LeTx caused ~70% of cell death in wild type cells, but less than 20% in TIR cells in 5
hours (Fig 3.1A). Cell death detected by LeTx was likely a pryroptotic cell death, since
cell death was prevented by knocking down caspase-1 (Fig. 3.1B).
3.1.2. TIR cell has no defects in intracellular incorporation of LeTx.
To further examine if TIR cells had no defects in incorporating LeTx into the cytoplasm,
we examined MEK1 cleavage and basal ERK and p38 activities inactivation in both wild
type and TIR cells exposed to LeTx for 3 hours (250ng/ml LF & 500ng/ml PA). There
was no apparent defect in MEK1 cleavage and dephosphorylation of ERK1 and 2, and
p38 in TIR cells when compared with wild type cells (Fig 3.2). Since LeTx inhibited
MEK cleavage leading to inhibition of the MAPK signaling cascade, cleavage of MEK1
and basal ERK and p38 indicates that TIR cells have no defects in intracellular
incorporation of LeTx.
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Fig 3.1. TIR cells are resistant to LeTx-induced pyroptosis.
(A) Both wild type (RAW 264.7 macrophage) and TIR cells were exposed to LeTx (LF
500ng /ml,1g/ml PA) for 5 hours. Then cell death was measured using MTT assay. (B)
Wild type cells were transfected with scrambled siRNA or siRNA targeting caspase-1 (siCASP1) for 48 hours. Cells were then treated with LeTx (500ng/ml LF and 1g/ml PA)
for 5 hours and cell death was measured by MTT assay. Data are expressed as means and
SD (n=3), * P≤ 0.05, **P≤0.01, and *** P≤0.005.
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Fig 3.2. TIR cell has no defects in incorporating LeTx into the cytoplasm.
Wild type (RAW 264.7 macrophage) and TIR cells were exposed to LeTx (250ng of LF
& 500ng of PA) for 3 hours. MEK N-terminal cleavage and phosphorylation of ERK1/2
and p38 were analyzed using immunoblots. p38 was used as loading control. Data are
representative of two independent experiments.
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3.2. TIR is mediated through an epigenetic mechanism(s).
3.2.1. Inhibition of DNMT or HDAC sensitizes TIR cells to LeTx-induced pyroptosis.
Based on the observation that TIR was a phenomenon sustained for 6 weeks after initial
treatments (~42 cycles of cell division), it is possible that an epigenetic mechanism(s) is
involved in the TIR process. To examine its involvement, wild-type and TIR cells were
treated with various chemical inhibitors targeting enzymes involved in epigenetic
reprogramming processes: tozasertib (broad spectrum aurora kinase inhibitor, 50nM),
azacitidine (broad spectrum DNA methylasetransferase inhibitor, 2.0M), panobionstat
(LBH-589, broad spectrum histone deacetylase inhibitor, 100nM), mocetinonstat (histone
deacetylase inhibitor targeting HDAC1, 2, & 3: 50nM), and anacardic acid (broad
spectrum histone acetyltransferase inhibitor 2.0M) for 24 hours. Different doses of each
epigenetic inhibitors were decided based on dose dependent study (Fig 3.3D). Cells were
then exposed to LeTx (500ng/ml LF & 1g/ml PA) for 5 hours and cell death was
measured using MTT assay. Among the inhibitors examined, azacitidine and
panobinostat significantly rendered TIR cells sensitive to LeTx-induced pyroptosis (Fig
3.3A).These results suggest that DNA methylation and histone deacetylation are involved
in TIR. Of note, mocetinostat had no effects on TIR, suggesting that HDAC 1, 2, and 3
may not be involved in TIR maintenance. Furthermore, TIR cells were pretreated with
azacitidine for various time points and sensitivity to LeTx was examined. As shown in
Fig 3.3B, TIR cells became sensitive to LeTx in a time-dependent manner, completely
regaining sensitivity to a similar level of wild-type cells in 48 hours. Panobinostat
rendered TIR cells sensitive to LeTx in a dose-dependent manner and full LeTx
sensitivity was reached at 100 nM concentration (Fig 3.3C).

3.2.2. LeTx induces global methylation in macrophages.
Since the DNA methyltransferase inhibitor, azacitidine sensitized TIR cells to LeTxinduced pryoptosis (Fig. 3.3A and B), I first examined whether LeTx induces global
DNA methylation in macrophages. The levels of global methylation were measured using
34

an ELISA (Enzyme linked immunosorbent assay) with antibody raised against
methylated CpG dinucleotide. Genomic DNAs were added to a specifically designed well
for high affinity to DNA and anti-body for CpG dinucleotide and secondary antibody
were subsequently added to read methylation level through optical density (O.D.). The
lowered concentration of LeTx (100ng/ml LF and 200ng/ml PA) for global methylation is
treated because high concentration of LeTx (500ng/ml LF and 1g/ml) is cytotoxic dose
and therefore it can kill most cells within 24hours. Wild type cells showed a very low
level of global DNA methylation (~1%), which was substantially increased (~11%) in
response to LeTx in a time-dependent manner (100ng LF/ml and 200ng PA/ml; Fig.
3.4A). The global DNA methylation was decreased in azacitidine-treated samples,
suggesting a role of DNA methyltransferases in the process. However, the increase of
global DNA methylation was not maintained in TIR cells (Fig. 3.4C), also suggesting that
global DNA methylation per se was not responsible for TIR. To examine the involvement
of NLRP1b in global DNA methylation, macrophages originating from C57BL/6 mice
harboring non-functional NLRP1b were treated with LeTx and global DNA methylation
was analyzed. The macrophages showed higher levels of basal DNA methylation, which
was further increased by LeTx (Fig. 3.4D). These results suggest that LeTx increased
global DNA methylation independent of NLRP1b/caspase-1.
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Fig 3.3. The DNMT and HDAC inhibitors sensitize TIR cells to LeTx-induced
pyroptosis.
(A) TIR cells were pretreated with 50nM tozasertib, 100nM panobinostat, or 2.0M
azacitidine, 50nM Mocetinostat, and 2.0m Anacardic acid for 24 hours. The inhibitor
doses were determined based on both dose-dependent studies with RAW 264.7
macrophage cells and IC values reported in literatures97-99. Non-treated wild type (WT;
RAW 264.7 macrophage), non-treated TIR or pre-treated TIR cells were newly seeded on
96 plates and exposed to LeTx (500ng/ml LF and 1g/ml PA) for 5 hours. (B) TIR cells
were cultured in the presence or absence of azactidine (2 ) for the times indicated.
Non-treated WT, TIR or azacitinde pretreated TIR cells were exposed to LeTx (500ng/ml
LF and 1mg/ml PA) for 5 hours. (C) TIR cells were cultured in the presence or absence of
panobinostat for doses indicated overnight. Non-treated WT, TIR, or pretreated TIR cells
were exposed to LeTx (500ng/ml LF and 1g/PA) for 5 hours (D) For dose dependent
studies, TIR cells were cultured in the presence and absence of varied epigenetic
inhibitors including Azacitidine, Anacardic Acid, Mocetinostat, and Tozasertib followed
by LeTx (500ng/ml LF and 1g/PA) for 5 hours. (A-D) Cell death was measured using
MTT assay. Data are expressed as means and SD (n=3), * P≤ 0.05, **P≤0.01, and ***
P≤0.005.
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D) Dose dependent study
I. Azacitidine
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III. Anacardic Acid
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Fig 3.4. Global DNA methylation levels in TIR were not different from those of wild
type cells.
(A) Genomic DNA was purified from wild type cells (WT: RAW 264. 7 macrophages)
and wild type cells treated with LeTx (100ng/ml LF & 200ng/ml PA) for times indicated.
(B) Genomic DNA was purified from wild type and wild type treated with LeTx (100ng
LF/ml & 200ng PA/ml) for 24 hours, and wild type treated toxin for 24 hours and
subsequently treated with 2.0M azacitidine overnight. (C) Genomic DNA was purified
from wild type and TIR cells. (D) Genomic DNA was purified from macrophages
prepared from C57BL/6 mice (C57 cells) and C57 cells treated with LeTx (100ng/ml LF
& 200ng/ml PA) for 24 hours. (A-D) Global methylation levels were measured using
global methylation ELISA kit (Epigentek, USA), following the protocol provided by the
manufacturer. Data are expressed as means and SD (n=3), * P≤ 0.05, **P≤0.01, and ***
P≤0.005 (student’s t-test).
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3.2.3. DNMT1 is involved in the maintenance of TIR.
Although global DNA methylation was not found to be related to TIR, DNA
methyltransferase (DNMT) activity was required for maintaining TIR (Fig 3.3). To
identify specific DNMTs involved in TIR, expression of DNMT1, DNMT3a, and
DNMT3b was analyzed using real-time quantitative PCR (qPCR) analysis. As shown in
Fig 3.5A, expression of DNMT1 was higher than 2-fold in TIR cells than wild type cells,
but no significant changes were detected in the levels of DNMT3a and rather a slight but
significant decrease of DNMT3b. Also, wild type cells were pretreated with LeTx for
various time points, and mRNA levels of DNMT1 were examined. As shown in Fig 3.5B,
mRNA of DNMT1 was increased in a time-dependent manner, suggesting that LeTx
caused increase of DNMT1 and DNA methylation. These results suggest that DNMT1
played a key role in TIR. To further confirm that the correlation between DNMT1
expression and TIR, multiple TIR and wild type cell clones were examined for DNMT1
expression. Consistent with the notion, expression of DNMT1 was closely related with
cell death resistance by LeTx with correlation coefficient (R2=0.8) as shown in Fig 3.6.
To functionally validate the role of DNMT1 in TIR, DNMT1 was knocked down using
DNMT1-specific siRNAs in TIR cells (Fig 3.7A). DNMT1-specific but not scrambled
si-RNAs knocked down about 60% of DNMT1 mRNAs (Fig 3.7A) and sensitized TIR
cells to LeTx (Fig. 3.7B). Global methylation was measured using genomic DNA
purified from DNMT1 specific knocked down wild type followed by LeTx treatment for
24 hours. Though LeTx-treated wild type showed a 5 fold increase in global methylation
level, knock down of DNMT1 did not show an increase of methylation, suggesting that
DNMT1 plays a role in global methylation induced by LeTx (Fig 3.7C).
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Fig 3.5. DNMT1 is up-regulated in TIR.
(A) mRNAs from wild Type (RAW 264.7 macrophage) and TIR cells were collected and
analyzed for the expression of DNMT1, DNMT3a, and DNMT3b, relative to GAPDH by
quantitative real-time PCR. (B) mRNAs from wild type (RAW 264. 7 macrophage) and
wild type treated with LeTx (100ng LF & 200ng PA) for times indicated were collected
and analyzed for DNMT1 mRNA levels. Data are expressed as means and SD (n=3), *
P≤ 0.05, **P≤0.01, and *** P≤0.005 (student’s t-test).
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Fig 3.6. TIR is correlated with upregulation of DNMT1 expression. Five TIR clones
with different sensitivities and one wild type (RAW 264.7 macrophage) clone were
analyzed for DNMT1 mRNA levels using quantitative real time PCR analysis. Cell death
levels were measured using MTT assay after treating cells with LeTx (LF 500ng/ml, PA
1g/ml) for 5 hours. Correlation between cell death and DNMT1 expression was
calculated using the Graphpad program (R2= correlation coefficient). Data are expressed
as means and SD (n=3).
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100

Fig 3.7. Inhibition of DNMT1 sensitizes TIR cells to pyroptosis.
(A) Quantitative real time PCR analysis of siRNA knock down of DNMT1 in RAW
264.7 cell. TIR cells were transfected with scrambled or DNMT1 targeting (si-DNMT1)
siRNAs for 48 hours. Treated cells were processed for total RNA purification and cDNA
preparation to analyze knock down efficiency by quantitative RT-PCR. Data were
normalized by the GAPDH expression levels in each sample. (B) TIR cells were
transfected with scrambled or DNMT1 targeting siRNA (si-DNMT1) for 48 hours
followed by treatment with LeTx (500ng/ml LF and 1g/ml PA) for 5 hours. Cell death
was then measured by MTT. (C) Wild type (RAW 264. 7 macrophage) were transfected
with scrambled siRNAs or siDNMT1 for 48 hours and then treated with LeTx (100ng LF
& 200ng PA) for 24 hours. Global methylation rates of surviving cells were then
measured. Data are expressed as means and SD (n=3), * P≤ 0.05, **P≤0.01, and ***
P≤0.005 (Student’s t-test).
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3.2.4. HDAC8 is involved in maintenance of TIR.
Following up the chemical inhibitor experiments (Fig 3.3), expression of various HDACs
including HDAC1, 2, 5, 8, and 9 were analyzed using qPCR. Among them, HDAC8 and
9 were up-regulated more than 2 fold in TIR cells, whereas HDAC 1, 2, and 5 were
down-regulated (Fig. 3.8). These results suggest that HDAC 1, 2 and 5 were not involved
in TIR maintenance, which is consistent with the HDAC 1, 2 and 3 inhibitor mocetinostat
results that showed no effects on TIR cells (Fig 3.3A). When multiple LeTx-sensitive and
resistant clones were examined for HDAC8 expression levels, a strong correlation
between expression of HDAC8 and TIR phenotypes (R2 =0.79) was shown.

To further confirm the role of HDAC8 in TIR, HDAC 8 was knocked down with
HDAC8-specific si-RNAs and examined for LeTx sensitivity. As expected, HDAC8specific si-RNA down-regulated HDAC8 expression and TIR cells knocked down
became sensitive to LeTx-induced pyroptosis but not in scrambled si-RNAs (Fig3.10A &
B). Global methylation was measured using genomic DNA purified from HDAC8
specific knocked down wild type cells followed by LeTx treatment for 24 hours.
Though LeTx treated wild type showed a 5 fold increase in global methylation level,
HDAC8 knockdown did not show an increase in methylation, suggesting that HDAC8
also plays a role in global methylation induced by LeTx (Fig 3.10 C).
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Fig 3.8. HDAC8 & HDAC9 are upregulated in TIR.
mRNAs from wild type (RAW 264.7 macrophage) and TIR cells were collected and
analyzed for HDAC1, 2, 5, 8, and 9 by quantitative real-time PCR. Data are expressed as
means and SD (n=3), * P≤ 0.05, **P≤0.01, and *** P≤0.005 (Student’s t-test).
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Fig 3.9. TIR is correlated with HDAC8 upregulation. Five TIR clones with different
sensitivities and one wild type (RAW 264.7 macrophage) clone were analyzed for
HDAC8 mRNA levels using quantitative real time PCR analysis. Cell death levels were
measured using MTT assay after treating cells with LeTx (LF 500ng/ml, PA 1g/ml) for
5 hours. Correlation between cell death and HDAC8 expression was calculated using the
Graphpad program (R2= correlation coefficient). Data are expressed as means and SD
(n=3).
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Fig 3.10. Inhibition of HDAC8 sensitizes TIR cells to pyroptosis.
(A) Quantitative real time PCR analysis of siRNA knock down of HDAC8 in RAW
264.7 cells. TIR cells were transfected with scrambled or HDAC8 targeting (si-HDAC8)
siRNAs for 48 hours. Treated cells were processed for total RNA purification and cDNA
preparation to analyze knock down efficiency by quantitative RT-PCR. Data were
normalized by the GAPDH expression levels in each sample. (B) TIR cells were
transfected with scrambled or HDAC8 targeting si-RNAs (si-HDAC8) for 48 hours,
followed by treatment with LeTx (500ng/ml LF and 1g/ml PA) for 5 hours. Cell death
was then measured by MTT. (C) Wild type cells (RAW 264.7 macrophage) were
transfected with scrambled siRNA or si-HDAC8 for 48 hours followed by treatment of
LeTx (100ng LF & 200ng PA) for 24 hours. Global methylation rates were measured for
each sample. Data are expressed as means and SD (n=3), * P≤ 0.05, **P≤0.01, and ***
P≤0.005 (Student’s t-test).
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3.3. Down-regulation of BNIP3 & BNIP3L is mediated through DNMT1
and HDAC8.
3.3.1. DNMT1 is involved in the down regulation of BNIP3& BNIP3L in TIR cells.
We previously documented that TIR is in part mediated by down-regulation of BNIP3
and BNIP3L50. Indeed, TIR cells expressed BNIP3 and BNIP3L to 40% of the levels
expressed in wild type cells (Fig 3.11). TIR cells treated with azacitidine (2.0M
Azacitidine for 24 hours) significantly up-regulated expression of both BNIP3 and
BNIP3L at the mRNA levels up to 10- and 15-folds, respectively, (Fig 3.12). Similarly,
knocking down DNMT1 by siDNMT1 up-regulated expression of BNIP3 (~8-fold) and
BNIP3L (20-fold) in TIR cells (Fig 3.13), suggesting that methylation by DNMT1 is
involved in down regulation of BNIP3 and BNIP3L.
3.3.2. Methylations in CpG Islands of BNIP3 & BNIP3L are not involved in TIR.
To examine whether TIR cells harbor higher levels of methylation in CpG islands of
BNIP3 and BNIP3L, both conventional bisulfite sequencing and pyro-sequencing
methods were used. Bisulfite treatment is most commonly used method to identify 5
methyl cytosine, m (5)-c, which is methylated cytosine by DNA methyltransferase. This
experimental approach is based on the principle that methylation happened on the
cytosine residue of dinucleotide CpG, and treatment of DNA with bisulfite deaminated
cytosine, producing unmethylated cytosine residues to urasile, but left 5-methylcytosine
residues unaffected as cytosine100.This, by PCR, is converted to thymine. The final result
is the creation of an artificial single nucleotide polymorphism (C, if methylated, and T if
not methylated) that can be analyzed using several common sequencing techniques101.
After bisulfite treatment, one of the CpG islands identified in the gene encoding BNIP3
was amplified and sequenced using a conventional cloning method as previously
described in methods section (Section 2.8.1). Sequencing five of the clones from wild
type and TIR cells showed no methylation in the CpG island of BNIP3 (Fig 3.14B).
Pyroassay is a powerful sequencing method which detects nucleotide incorporation by
proportional emission of light in each pyrosequencing cycle102, 103. For methylation
analysis, biotin labeled, single stranded PCR products generated from bisulfite-treated
DNA were used as a template with an internal primer104. Pryoassay can quantify
61

methylation frequencies in CpG islands and distinguish between methylated and
unmethylated sequences. I prepared genomic DNA from wild type RAW 264.7
macrophage and TIR cells and Qiagen conducted bisulfite treatment followed by
pyroassay. In line with the previous conventional bisulfite sequencing results, bisulfite
pyroassay showed that 13 consecutive positions in longest CpG Islands of BNIP3 and
BNIPL in wild-type and TIR cells were mostly unmethylated and no apparent differences
were detected (Fig 3.15). However, the size for bisulfite sequencing for both
conventional and pyroassay is limited up to 400 bp as upper limit due to DNA
fragmentation which can occur during the bisulfite treatment101. In addition, the high
redundancy of the target sequence due to the original GC richness creates long stretches
of thymines, which are often difficult to read for the polymerases105. Hence, extensive
regions of CpG islands in BNIP3 and BNIP3L which can be more than 1000 bp long are
still to be sequenced.
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Fig 3.11. Bnip3 and Bnip3L are down regulated in TIR. mRNA expressions of (A)
BNIP3 and (B) BNIP3L were analyzed relative to GAPDH by using real time
quantitative PCR in wild Type (RAW 264.7 cells) and TIR cells. Data are expressed as
means and SD (n=3), * P≤ 0.05, **P≤0.01, and *** P≤0.005 (student’s t-test).
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Fig 3.12. The DNA methyltransferase inhibitor azacitidine induces BNIP3 &
BNIP3L expression in TIR cells. Wild Type (RAW 264.7 macrophage) and TIR cells
were pretreated with 2.0M azacitidine for 24 hours and mRNA levels of (A) BNIP3 and
(B) BNIP3L relative to GAPDH were measured by real-time PCR. Data are expressed as
means and SD (n=3), * P≤ 0.05, **P≤0.01, and *** P≤0.005 (Student’s t-test).
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Fig 3.13. Knocking down DNMT1 by siRNA enhances BNIP3 and BNIP3L
expression in TIR cells.
(A) Quantitative real time PCR analysis of siRNA knock down of DNMT1 in RAW
264.7 cell. TIR cells were transfected with scrambled or DNMT1 targeting (si-DNMT1)
siRNAs for 48hrs. Treated cells were processed for total RNA purification and cDNA
preparation to analyze knock down efficiency by quantitative RT-PCR. Data were
normalized by the GAPDH expression levels in each sample (B) TIR cells were
transfected with scrambled siRNAs or DNMT1 targeting siRNAs (si-DNMT1) for 48
hours and expression of BNIP3 and BNIP3L were analyzed by real time quantitative
PCR. Data are expressed as means and SD (n=3), * P≤ 0.05, **P≤0.01, and *** P≤0.005
(Student’s t-test).
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Fig 3.14. CpG islands of BNIP3 was not methylated.
(A) The CpG islands of BNIP3 were identified using epigenomic tools from NCBI106. (B)
Genomic DNAs were purified from wild type and TIR cells and treated with bisulfite.
PCR was conducted with the bisulfite specific primers and sequences of amplicons
(125bp) were analyzed using bacterial cloning method as previously described in the
method section (Section 2.8.1). Open and closed circles respectively represent
unmethylated and methylated CpG dinucleotides (Black circle: methylated, White circle:
unmethylated), respectively (N=5) (C) Sequence information of amplicon after untreated
and treated bisulfite treatment for both wild type and TIR cells were identified.
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A) CpG Islands of BNIP3

B)
Bisulfite sequencing of CpG Island of BNIP3 (125bp)
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Fig 3.15. Pyroassay analysis of methylated BNIP3 & BNIP3L
Bisulfite pyroassay was conducted to analyze methylation status of 13 consecutive
positions in CpG islands of (A) BNIP3 & (B) BNIP3L. (C) Methylation levels were
calculated using Pyro Q-CpG software. The assays were performed by Qiagen (Maryland,
USA).
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C)
Table 3.1. Bisulfite pyroassay results of BNIP3 & BNIP3L
Metyhlation (%)
Gene

BNIP3

BNIP3L

Positive
Ctrl

Type

Position No.
1

2

3

4

5

6

7

8

9

10

11

12

WT

5.84

4.92

3.19

1.96

3.92

2.45

3.67

2.65

6.94

3.57

9.32

2.53

TIR

5.35

4.25

2.70

2.43

2.95

3.41

4.35

2.79

5.43

2.90

9.27

2.56

WT

2.79

7.42

2.98

3.27

2.15

6.16

2.4

2.18

2.22

3.12

3.93

1.96

TIR

2.97

7.67

3.27

2.93

2.04

6.37

1.98

2.32

2.03

3.31

4.26

1.67

WT

3.11

8.13

3.07

3.73

1.53

4.33

2.58

2.20

1.99

3.49

4.52

1.54

Meth*

98.4

100

91.2

99.4

86.5

100

89.3

84.6

85.2

100

97.5

NA

*: Methylated positive control
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3.3.3. HDAC8 is involved in the down-regulation of BNIP3 & BNIP3L in TIR cells.
HDAC8 expression was increased in TIR cells (Fig 3.8) and knocking it down by
siRNAs sensitized TIR cells to LeTx-induced pyroptosis (Fig 3.10). Therefore, I
examined whether knocking down HDAC8 enhanced BNIP3 and BNIP3L expression in
TIR cells. As expected, TIR cells treated with HDAC8 targeting siRNAs induced a 14
fold and 30-fold higher expression of BNIP3 and BNIP3L, respectively, than those of
non-treated TIR cells (Fig 3.16). Collectively, together with the previous DNMT1
knocking down (Fig 3.11), down-regulation of BNIP3 and BNIP3L in TIR cells was
likely mediated through epigenetic mechanisms involved in both DNA methylation and
histone deacetylation.
3.3.4. Deacetylation at histone 3 lysine 27 (H3K27) is involved in down regulation of
BNIP3 & BNIP3L expression.
Since HDAC8 was shown to be involved in TIR and suppression of BNIP3 and BNIP3L,
histone acetylation could have been involved in TIR maintenance. To find targets of
HDAC8 responsible for BNIP3 and BNIP3L expression, acetylated histones binding to
BNIP3 and BNIP3L encoding gene were searched through the genome-wide epigenetic
marker database107 (ENCODE) and we found that histone H3 acetylated at lysine 27
(H3K27Ac) was shown to be commonly involved in expression of both BNIP3 and
BNIP3L107(Fig 3.17). Indeed, Western blot analysis using H3K27Ac-specific antibodies
showed 5-fold higher levels of overall H3K27Ac immunoreactivity in wild type than TIR
cell extracts (Fig 3.18). Also, treatments of panobinostat (100nM) showed a 9 fold
increase and treatment of azacitidine (2.0M) showed a 12 fold increase in H3K27Ac
levels compared to non-treated TIR (Fig 3.18). These results collectively suggest that TIR
cells suppress BNIP3 and BNIP3L through deacetylating and methylatng H3K27, which
at least in part renders resistance to LeTx-induced pyroptosis in TIR cells. In addition,
ChIP (Chromatin Immunoprecipitation) assay showed that H3K27Ac was enriched in
wild type whereas it is down regulated in TIR for BNIP3 expression, suggesting that
H3K27Ac functions as an enhancer for the expression of BNIP3 (Fig 3.19A) through
histone modification. However, enrichment of H3K27Ac in wild type did not show
significant difference compared to TIR for BNIP3L expression (Fig 3.19B), suggesting
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that other enhancers such as H3K9Ac or H3K36Ac or histone methylation of H3K4Me3
are involved to regulate expression of BNIP3L.
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Fig 3.16. Knocking down HDAC8 by siRNAs enhances BNIP3 & BNIP3L
expression in TIR cells.
(A) Quantitative real time PCR analysis of siRNA knock down of HDAC8 in RAW
264.7 cell. TIR cells were transfected with scrambled or HDAC8 targeting (si-HDAC8)
siRNAs for 48 hours. Treated cells were processed for total RNA purification and cDNA
preparation to analyze knock down efficiency by quantitative RT-PCR. Data were
normalized by the GAPDH expression levels in each sample (B) TIR cells were
transfected with scrambled siRNAs or HDAC8 targeting siRNAs (si-HDAC8) for 48hrs
and expression of BNIP3 and BNIP3L were analyzed by real time quantitative PCR. Data
are expressed as means and SD (n=3), * P≤ 0.05, **P≤0.01, and *** P≤0.005 (Student’s
t-test).
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Fig 3.17. Histone modification profiles of H3K27Ac which interact with BNIP3 and
BNIP3L. Histone modification site search using ENCODE107, 108, the signal of H3K27Ac
targeting (A) BNIP3 and (B) BNIP3L where histone modification occur were identified
in the promoter region (Arrow → indicates primer design site for ChIP assay). Snap shot
of from UCSC genome browser was taken showing for GC %, CpG islands, Chip-Seq for
histone modification for the bone marrow derived macrophage cell line (BMDM).
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Fig 3.18. Histone modification site for down regulation of BNIP3 gene expression in
TIR (A) Expression of H3K27Ac in wild type (RAW 264.7 macrophage) and TIR were
analyzed using immunoblots. -actin was used as loading controls. (B) TIR cells were
pretreated with histone deacetylase inhibitor (100 nM Panobinostat: PN) or DNA
methyltransferase (2.0 M Azacitidine: Aza) inhibitor and levels of H3K27 acetylation in
wild type and TIR were analyzed using immunoblots. Immunoreactivity of H3K27Ac
was analyzed using NIH image program. Data are representative of three independent
experiments. Data are expressed as means and SD (n=3), * P≤ 0.05, **P≤0.01, and ***
P≤0.005 (Student’s t-test).
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Fig 3.19. H3K27Ac binding to the promoter regions of BNIP3 is suppressed in TIR.
Promoter binding of the BNIP3 and BNIP3 to H3K27Ac was evaluated by Chromatin
Immunoprecipitation (ChIP) analysis. Genomic DNAs from wild type (RAW 264.7
macrophages) and TIR cells were prepared, sonicated, and, immunoprecipitated using
antibodies against H3K27Ac, and control IgG. Immunoprecipitated DNAs were
analyzed by quantitative real-time PCR using primers for (A) BNIP3 and (B) BNIP3L.
For ChIP efficiency, % of input DNA recovered by immunoprecipitation, was determined
by quantitative real-time PCR. Rabbit IgG serum was used as a background control.
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CHAPTER 4 - DISCUSSION
Epigenetic reprogramming is a cellular mechanism of gene regulation persisting
throughout cell division. Here, I showed that toxin induced resistance (TIR) was an
epigenetic adaptation of macrophages to LeTx-induced pyroptosis. Previously, several
mechanisms of TIR were suggested. Salles et al. reported an adaptive ERK activation by
a MEK-independent process or a general decrease in proteasome activity was known to
be partially involved69. We previously have found that BNIP3 and BNIP3L were down
regulated in TIR50, conferring resistance to pyroptosis. Further, TIR cells were resistant
to NLRP-1 inflammasome induced mitochondrial dysfunction, including mitochondrial
inner membrane hyperpolarization, generation of reactive oxygen species (ROS), and
depletion of the anti-oxidants55. However, specific mechanism how BNIP3 and BNIP3L
were down regulated in TIR cells is still elusive and the mechanism needs to be further
explored. In this study, we reported that DNMT1 and HDAC8 were required for
maintaining TIR and it suppresses BNIP3 and BNIP3L in TIR. Also, H3K27Ac was
decreased in TIR cells and it subsequently suppresses BNIP3. A previous study showed
that LeTx inhibits histone H3 phosphorylation on serine 10 (H3S10) and suppresses IL-8
production109. It was speculated that the cleavage of MEKs by LeTx, resulting in their
inactivation, is responsible for the lack of H3S10 phosphorylation, since the
phosphorylation is mediated by the mitogen and stress-activated kinase (MSK) which is
activated by p38 and ERKs. However, since TIR cells were normal in basal p38 and ERK
activities (Fig 3.2), H3S10 phosphorylation is expected to be normal in TIR cells. This
study detected a significant and rapid increase of global DNA methylations by LeTx
treatments (Fig 3.4A), which was prevented by the DNMT inhibitor azacitidine and
siRNAs targeting DNMT1 (Fig 3.4B &D). These results suggest that up-regulation of
DNMT1 was responsible for at least in part of global DNA methylation induced by LeTx.
Global DNA methylation was also detected in macrophages harboring non-functional
NLRP1b (Fig 3.4D), suggesting that activation of NLRP1b was not involved in the
changes. Other studies have also shown that LeTx inhibits phosphatidylinositol 3-kinase
(PI3K) and protein kinase B (Akt) signaling cascades110. As mentioned earlier, high
global DNA methylation by LeTx was not maintained in TIR cells (Fig 3.4C) and thus
global DNA methylation per se was not likely involved in TIR. Interestingly, TIR cells
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expressed a higher level of DNMT1 than those of wild type and the extent of LeTxinduced pyroptosis was negatively correlated with the levels of DNMT1 expression (Fig
3.6). These results suggest that DNA methylation at specific genome sites through
DNMT1 was required for TIR maintenance; however, the identities of the genes are
unknown.
Since DNMT1 was required for TIR, I further examined whether BNIP3/BNIP3L
expression in TIR cells could be restored by the DNMT chemical inhibitor azacitidine
and siRNAs targeting DNMT1. Indeed, suppression of BNIP3 and BNIL3L expression in
TIR cells required at least in part DNMT1-mediated DNA methylation (Fig 3.3 & 3.7).
However, DNA methylations in the promoter regions encoding BNIP3 and BNIP3L were
not different between wild type and TIR cells (Fig 3.14). Considering the limits of this
study in the number of bisulfite sequence analysis performed using the conventional
cloning method (Fig 3.14B) and partial sequence by the pyroassay (Fig 3.15). In addition,
suppression of BNIP3/BNIP3L by DNMT1 could have been mediated through
suppression of other genes that positively regulate BNIP3/BNIP3L expression.
In addition to DNMT1, experiments with chemical inhibitors for enzymes involved in
epigenetic reprogramming indicated that HDACs were required for maintaining TIR (Fig.
3.3). Also the broad spectrum HDAC inhibitor panobionostat, but not HDAC1,2 and 3specific mocentinostat, rendered TIR cells sensitive to LeTx-induced pyroptosis (Fig.3.3),
indicating that HDACs other than HDAC1,2, and 3 were required for TIR, Furthermore,
qPCR analysis showed that HDAC8 and HDAC9, but not HDAC1, 2 and 5, were upregulated in TIR cells. TIR cells became sensitized to LeTx-induced pyroptosis when
HDAC8 was specifically knocked down by siRNAs. Collectively, these results suggested
that HDAC8 was involved in the resistance mechanism of TIR cells. HDAC8 is a
member of the class I histone deacetylase family. It forms transcriptional repressor
complexes by associating with many different proteins (including pRb-E2F and mSin3A),
and plays an important role in transcriptional regulation, cell cycle progression, and
developmental events. HDAC8 also may play a role in smooth muscle cell contractility111.
Gao et al. reported that knockdown of HDAC8 resulted in the increased expression of
JAK2/STAT signaling leading to cytokine signaling in K562 and HEL cells112.
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Histone modification by HDAC and histone methylases can suppress BNIP3/BNIP3L
expression. Given that DNA methylations in the promoter regions of BNIP3 and BNIP3L
were not involved, histone acetylation levels could have contributed to their gene
expressions in TIR cells. Several studies have elucidated that BNIP3 expression is
regulated by epigenetic mechanisms such as DNA methylation and histone deacetylation
and how transcription factor, Hypoxia Inducible Factor (HIF-1) influences expression of
BNIP3 under hypoxic conditions68, 92, 113-115. For example, Murai et al. showed that
BNIP3 expression was suppressed in hematopoietic tumors and it could be restored by
the treatments of methyltransferase inhibitor, azacitidine68, leading to hypoxia-mediated
cell death. When they measured the acetylation of histone H3 in the 5’ region of the gene
using ChIP assays, gene expression was correlated with acetylation and inversely
correlated with DNA methylation, suggesting that DNA methylation in the 5’ CpG
islands and histone H3 deacetylation responsible for silencing BNIP3 expression68.
Previously, several studies demonstrated that DNMT1 and HDACs co-operatively work
and induce gene silencing94. For example, Jones et al. suggested that methylated DNA
assembled into chromatin and it binds to the transcription repressor MeCP2 as a
methylation-specific transcriptional repressor, which recruits Sin3 histone deacetylase
complex94.
By using HDAC inhibitors in vitro system, several effects on the expression of many
genes have been shown, resulting in cell differentiation, inhibition of proliferation and
induction of apoptosis92, 112, 115. Underlying mechanism of HDAC inhibitors affecting on
gene expression is described as acetylation, resulting in increased recruitment of
transcription factors, which result is increased in expression of particular genes. However,
HDACs can render gene suppression through targeting non-histones. For example, Zhou
et al. showed that inhibition of HDAC1 increased ubiquitin-dependent proteasomal
degradation of DNMT1, suggesting that HDACs is directly involved in regulation of
DNMT1 stability116. Further Du et al. suggested that DNMT1 was destabilized by
acetylation driven ubiquitination, through targeting DNMT1 for proteasomal degradation.
On the other hand, HDAC1 and deubiquitinases such as HAUSP (Herpes virus associated
ubiquitin specific protease) stabilized DNMT1117.
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Since HDAC8 was shown to be required for TIR, I further examined how histone
deacetylation could influence BNIP3 and BNIP3L expression. Based on the ENCODE
genome-wide epigenetic reprograming data base search107, H3K27Ac was identified as a
common enhancer for both BNIP3 and BNIP3L expression (Fig 3.17). Through Western
blots and chromatin immunoprecipitation assay (ChIP), I examined whether H3K27Ac
was decreased in TIR cells. As expected, the levels of H3K27Ac were substantially
diminished in TIR cells, and TIR cells exposed to the HDAC inhibitor panobinostat or
DNMT inhibitor azacitidine restored H3K27Ac levels (Fig 3.18). ChIP assays using
H3K27Ac specific antibodies showed that H3K27Ac strongly interacted with the
promoter regions of BNIP3 but not BNIP3L in wild-type cells, which was significantly
diminished in TIR cells (Fig 3.19A). These results suggest that H3K27Ac is possibly
deacetylated by HDAC8, and resulted in the suppression of BNIP3 expression in TIR
cells. Unlike BNIP3, occupancy of H3K27Ac of the BNIP3L promoter was about 10 fold
less in both wild type and TIR than those of BNIP3 (Fig 3.19B), suggesting that
H3K27Ac did not sufficiently present in the promoter region of BNIP3L (Fig 3.19B). I
speculate that histone acetylation of H3K27 in BNIP3L promoter region less frequently
occurs and histone deacetylase will not be recruited to down regulate expression of
BNIP3L. Though, H3K27Ac minimally contributed expression of BNIP3L, other histone
modifications such as histone methylation and acetylation of other regions such as
H3K9Ac or H3K36Ac may be involved. The ENCODE genome-wide epigenetic
reprograming data base search also identified H3K9Ac and H3K36Ac as histone
modification marker for BNIP3 and BNIP3L gene expression in leukemia cell line,
respectively107. It has been previously reported that acetylation of H3K36 and H3K9
leads to activation of gene transcription as enhancer118, 119. It also has been shown that
histone methylation enhances gene transcription; it is possible that mono methylation of
H3K4 and H3K9, and tri methylation of H3K4 in BNIP3L activate gene transcription120.
Examining the role of these acetylation sites of H3 in BNIP3 and BNIP3L expression will
need to be further explored and it will provide insights into the mechanism of HDAC8 in
TIR.
In summary, TIR cells induced high levels of DNMT1 and HDAC8 expression, which
was responsible for maintaining TIR and suppressing expression of the cell death genes
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BNIP3 and BNIP3L (Fig 4.1), conferring resistance in TIR cells. Although the
mechanism of DNMT1 in TIR was undetermined, HDAC8 could have suppressed the
expression of BNIP3 through deacetylating histones such as H3K27Ac. This study for the
first time elucidates epigenetic mechanisms of TIR cells in macrophage.
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Fig 4.1. BNIP3 and BNIP3L are down regulated through epigenetic mechanism
mediated via DNMT1 and HDAC8. LeTx induces methylation in RAW 264. 7
macrophage cells and TIR and BNIP3 and BNIP3L partially methylated in TIR. LeTx
subsequently recruits HDAC8, leading to down regulation of BNIP3 and BNIP3L. (Blue
indicates unmethylated DNA and red indicates methylated DNA.)
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4.1. Further study
This study provided valuable information on the role of epigenetic reprograming in TIR.
However, multiple limitations were also identified in this study. To further elucidate the
mechanisms of TIR, the following experiments are suggested:
4.1.1. Validation of methylation status of BNIP3 and BNIP3L by genome sequencing
Methylation of BNIP3 and BNIP3L should be confirmed through complete genome
sequencing to overcome limitation of bisulfite sequencing. In the present study, BNIP3
and BNIP3L were not methylated (Fig 3.14B & 3.15). However, use of bisulfite
sequencing also has some limitation and it is not sufficient to completely cover CpG
island, which is longer than 400bp121. Because DNA fragmentation can occur during the
bisulfite treatment, amplicon size for both bisulfite genomic sequencing and pyroassay is
limited up to ~400 and 500bp. In addition, the high redundancy of the target sequence
due to the original GC richness creates long stretches of thymines, which are often
difficult to read for the polymerases. This problem can be overcome by complete genome
sequencing through next generation sequencing (NGS) and it may provide conclusive
answers for the questions. Using the Illumina sequencing, I foresee that results in this
study will be precisely confirmed.
4.1.2. Indirect suppression of BNIP3 and BNIP3L by PI3K/Akt
In the present study, the sequence of unmethylated BNIP3 and BNIP3L showed that
direct DNA methylation did not occur (Fig 3.14 & 3.15). As previously mentioned, this
methylation should be validated. However, if the validation result does not show that
CpG islands of BNIP3 and BNIP3 are not methylated, it is possible to approach this
matter with indirect down regulation of BNIP3 by activation of PI3K/Akt pathway. It was
reported that NF-B activation located downstream signaling pathway of PI3K/Akt is
crucial for the silencing of BNIP3 through E2F1-dependent gene transcription114. Also,
we previously reported that activation of PI3K/Akt leads to cell cycle recovery from cell
cycle arrest induced by LeTx in human acute monocytic leukemia cell line, THP-1 cell122.
The linkage between cell cycle recovery via PI3K/Akt activation and toxin induced
resistance mechanism by down regulation of BNIP3 & BNIP3L should be examined. It
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will provide insight how Akt activation by LeTx leads to activation of NF-B, resulting
in suppression of BNIP3 and BNIP3 in TIR.
4.1.3. Mechanism of recruitment between methylated BNIP3/BNIP3L by DNMT1 &
HDAC8
Mechanism showing how DNMT1 and HDAC8 cooperatively act together for
suppression of BNIP3 and BNIP3L should be examined in depth. We have found that
DNMT1 and HDAC8 are involved in down regulation of BNIP3 and BNIP3L (Fig 3.13,
3.16 & 3.18). We should decipher the underlying mechanism how DNMT1 cooperatively
interacts with HDAC8 for the repression of transcription, leading to silence of BNIP3 and
BNIP3L. It has been reported that methylated DNA in chromatin binds to the
transcription repressor proteins, MeCP2 and MBD2, which in turn recruit histone
deacetylase, and forms histone deacetylase complex, leading to repression of genes94, 95.
For this goal, I suggest that increased expression of MBD and MeCP2 in TIR should be
examined using quantitative real time PCR. Also, immunoprecipitation will allow us to
examine if methylation of BNIP3 and BNIP3L or other possible cell death genes by
DNMT1 in TIR will bind to MeCP2 and MBD2 and subsequently recruits histone
deacetylase complex. At the same time, it should be examined that if HDAC8 are
recruited to this histone deacetylase complex.
4.1.4. Roles of HDAC8 and HAT for BNIP3/ BNIP3L expressions in histone
modification
For histone modification, the present study showed that H3K27Ac as an enhancer was
down regulated in TIR, leading to down regulation of BNIP3 based on Western Blot &
ChIP assay (Fig 3.18 & 3.19). However, the specific link between HDAC8 and
H3K27Ac for histone modification was not yet specifically addressed in this study.
Though it was shown that broad spectrum HDAC inhibitor, panobinostat restored
expression of H3K27Ac (Fig 3.18), we should also conduct further experiment to
determine if specific knock down of HDAC8 will lead to expression of H3K27Ac. In
addition, since BNIP3L expression was not affected by H3K27Ac, we should further
examine that BNIP3L expression was affected by other histone modification enhancers
such as H3K79Ac and H3K36Ac or histone methylation of H3K4me.
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We also found that other histone deacetylase 9 (HDAC9) showed a 2.5 fold increase in
TIR (Fig 3.8). In this study, we examined only HDAC8, which showed highest
expression. However, we should examine if expressions of HDAC9 is correlated with
resistance of TIR. If so, we should further examine if HDAC9 down regulates BNIP3 and
BNIP3L.
In terms of histone acetyl transferase (HAT), it is elusive if TIR cells will gain sensitivity
through HAT, leading to up-regulation of BNIP3 and BNIP3L. Therefore, we should
examine if acetylation of H3K27 by CBP (CREB binding protein)/ P300 protein which
has intrinsic histone acetyltransferase activity, will subsequently lead to increased
expression of BNIP3 and BNIP3L in TIR (Fig 4.1).
4.1.5. Effect of histone methylation on BNIP3/BNIP3L expression
Histone methylation is the modification of certain amino acids such as Lysine or
Arginine in a histone protein by addition of one, two, or three methyl groups123. Histone
methylation induces either transcriptional repression or activation. It was shown that
trimethylation of lysines (K) positioned on 4, 36, or 79 on H3 (H3K4me3, H3K36me3,
and H3K79me3, respectively), monomethylation of H4K20 and H2K5 (H4K20me and
H2BK5me) result in gene activation, whereas di- or trimethylation of H3K9 (H3K9me2
and H3K9me3) and H3K27 (H3K27me3) lead to gene repression82, 85. Trimethylation of
H3K4 (H3K4me3) was identified in BNIP3L through ENCODE site and it may lead to
activation of BNIP3L; Activation of H3K4me3 may lead to restoration of down regulated
BNIP3L by HDAC8. Further ChIP assay and Western blot will allow us to examine if
expression of BNIP3 and BNIP3L are affected by histone methylation.

4.2. Therapeutic potential
For the treatment of Anthrax, current therapy is limited to antibiotics such as
ciprofloxacin or doxycycline. In addition, the antibiotic treatment cannot be effective in
the case of inhalation infection; it can be 45% lethal even with treatment of antibiotics.
Though anthrax vaccine is available in the U.S military against bioterrorism, the vaccine
use for public is limited. Because it should be administered four times per year
accompanying with an annual booster, this can be a complicated procedure for patients
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and because of that, it can cause delay in the immunization schedule. At this moment, it
is not clear whether inducing TIR in macrophages or other cells is beneficial for the host
in anthrax. NLRP1b was shown to be required for early detection B. anthracis and
preventing anthrax in a mouse B. anthracis spore infection model40. The beneficial effect
of NLRP1b is likely due to early release of IL-1 and IL-18, which induces early
inflammatory responses during infection. However, in situations when antibiotics are
already in place, overt inflammation may not be beneficial for the host and thus
preventing NLRP1b activation could be beneficial. In addition, LeTx can be detrimental
to host considering that LeTx enhances dissemination of bacteria beyond the draining
lymphoid tissue, which could be mediated through pyroptosis. It was also shown that
LeTx-induced cytotoxicity in mice and rats is detrimental for the hosts33, 124. Therefore,
tailed therapies, preventing pyroptosis without affecting the IL-1 and IL-18, could be an
ideal approach for treating anthrax. Further studies elucidating the mechanism specific
for pyroptosis will provide new opportunities for developing novel interventions for
anthrax.
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